Toshitsugu Sugimoto

Bone Mineral Density Is not Sensitive Enough to Assess the Risk of Vertebral Fractures in Type 2 Diabetic Women

T. Sugimoto, Masahiro Yamamoto, M. Yamauchi, 2007, Calcified Tissue International.

Assessment using serum insulin-like growth factor-I and bone mineral density is useful for detecting prevalent vertebral fractures in patients with type 2 diabetes mellitus

I. Kanazawa, Ken-ichiro Tanaka, M. Notsu, 2018, Osteoporosis International.

Efficacy of weekly teriparatide does not vary by baseline fracture probability calculated using FRAX

J. Kanis, E. McCloskey, H. Johansson, 2015, Osteoporosis International.

Bone fragility in male glucocorticoid-induced osteoporosis is not defined by bone mineral density

T. Sugimoto, Toru Yamaguchi, Masahiro Yamamoto, 2009, Osteoporosis International.

Effect of alendronate on bone metabolic indices and bone mineral density in patients treated with high-dose glucocorticoid: a prospective study

T. Sugimoto, H. Kaji, F. Kanda, 2010, Osteoporosis International.